Octagos Health, a medical technology company providing AI-powered cardiac device monitoring solutions, has secured over $43 million in a series B financing round to advance an AI-driven cardiac device monitoring platform. Founded in 2020 by Shanti Bansal, the company’s latest funding round was led by Morgan Stanley Expansion Capital, with significant support from Mucker Capital Octagos Health will use the new investment to fuel growth, accelerate advancements in cardiac device monitoring platforms, and expand the commercial team.
read more..